- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,197GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,264GBP
- Drug Pipelines
- July 2020
- 66 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Drug Pipelines
- March 2021
Global
From €1922EUR$2,000USD£1,652GBP
The Plague Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat and prevent the plague. Plague is a bacterial infection caused by the Yersinia pestis bacteria, which is spread through flea bites and contact with infected animals. Plague drugs are used to treat the infection and prevent its spread. These drugs are typically antibiotics, such as streptomycin, gentamicin, and doxycycline.
The Plague Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. These companies are constantly researching and developing new drugs to treat and prevent plague, as well as to improve existing treatments. Show Less Read more